Praxis Precision Medicines Inc logo

Praxis Precision Medicines Inc

NAS:PRAX (USA)   Ordinary Shares
$ 50.39 -0.75 (-1.47%) 09:30 AM EST
At Loss
P/B:
6.36
Market Cap:
$ 861.06M
Enterprise V:
$ 795.07M
Volume:
4.56K
Avg Vol (2M):
249.03K
Volume:
4.56K
At Loss
Avg Vol (2M):
249.03K

Business Description

Praxis Precision Medicines Inc logo
Praxis Precision Medicines Inc
NAICS : 541714 SIC : 2834
ISIN : US74006W2070

Share Class Description:

PRAX: Ordinary Shares
Description
Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. The firm is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal excitation-inhibition imbalance. The firm's pipeline covers PRAX-114, for the treatment of a broad range of patients suffering from major depressive disorder and post-traumatic stress disorder; PRAX-944, for the treatment of Essential Tremor and Parkinson's Disease; PRAX-562, and PRAX-222, among others.
Name Current Vs Industry Vs History
Cash-To-Debt 32.59
Equity-to-Asset 0.79
Debt-to-Equity 0.04
Debt-to-EBITDA -0.02
Interest Coverage N/A
N/A
N/A
Piotroski F-Score 5/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 13.32
Distress
Grey
Safe
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 57.61
9-Day RSI 49.98
14-Day RSI 49.48
6-1 Month Momentum % 220.65
12-1 Month Momentum % 238.81

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 5.39
Quick Ratio 5.39
Cash Ratio 5.16

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -51
Shareholder Yield % -10.86

Financials (Next Earnings Date:2024-05-10 Est.)

PRAX's 30-Y Financials
Income Statement Breakdown
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:PRAX

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Praxis Precision Medicines Inc Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 2.447
EPS (TTM) ($) -22.59
Beta 3.1
Volatility % 120.11
14-Day RSI 49.48
14-Day ATR ($) 4.191467
20-Day SMA ($) 52.608
12-1 Month Momentum % 238.81
52-Week Range ($) 12.449999 - 67.21
Shares Outstanding (Mil) 17.09

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 5
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Praxis Precision Medicines Inc Filings

Filing Date Document Date Form
No Filing Data

Praxis Precision Medicines Inc Stock Events

Financials Calendars
Event Date Price($)
No Event Data

Praxis Precision Medicines Inc Frequently Asked Questions

What is Praxis Precision Medicines Inc(PRAX)'s stock price today?
The current price of PRAX is $50.39. The 52 week high of PRAX is $67.21 and 52 week low is $12.45.
When is next earnings date of Praxis Precision Medicines Inc(PRAX)?
The next earnings date of Praxis Precision Medicines Inc(PRAX) is 2024-05-10 Est..
Does Praxis Precision Medicines Inc(PRAX) pay dividends? If so, how much?
Praxis Precision Medicines Inc(PRAX) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1